Advertisement

A Novel Mutation in ACAT1 Causing Beta-Ketothiolase Deficiency in a 4-Year-Old Sri Lankan Boy with Metabolic Ketoacidosis

  • Thivanka Vishwani ManawaduEmail author
  • Eresha Jasinge
  • Meranthi Fernando
  • Pradeep Gamage
  • Anusha Varuni Gunarathne
Case Report
  • 17 Downloads

Abstract

Beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency is a rare genetic disorder of ketone utilization and isoleucine catabolism caused by mutations in the ACAT1 gene. Here we report the first Sri Lankan case of T2 deficiency confirmed by genetic analysis. A 4-year-old boy presented with the first episode of severe metabolic ketoacidosis after a febrile illness. On admission, the child was drowsy and had circulatory collapse needing intubation. Initial investigations were not detective of a cause and symptomatic management did not improve the condition. During the acute episode, his urine organic acid profile revealed elevations in 3-OH-2-methyl-butyric acid and tiglylglycine whilst 2-methylacetoacetic acid was not detected. The differential diagnoses for the urine organic acid profile included deficiency in T2 or 2-methyl-3-OH-butyryl-CoA dehydrogenase enzymes. Genetic analysis using polymerase chain reaction and DNA sequencing of ACAT1 gene revealed that the proband is homozygous for the novel missense likely pathogenic variant c.152C > T p.(Pro51Leu) confirming the diagnosis of T2 deficiency. This case highlights the importance of suspecting T2 deficiency in the differential diagnosis of pediatric metabolic ketoacidosis in preventing life threatening consequences of an otherwise benign disorder.

Keywords

Beta-ketothiolase deficiency Metabolic ketoacidosis Urine organic acid ACAT1 Tiglylglycine 

Notes

Acknowledgements

We acknowledge Prof. Arndt Rolfs, CEO, Centogene AG, Germany and Prof. Peter Bauer, Chief Scientific Officer, Human Geneticist at Centogene AG, Germany for free of charge genetic analysis.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Compliance with Ethical Standards

Conflict of interest

The authors declare that there is no conflict of interest on the research, authorship, and/or publication of this article.

Informed Consent

Signed informed consent was obtained from the patient’s parents for publication of the manuscript.

References

  1. 1.
    Abdelkreem E, Otsuka H, Sasai H, Aoyama Y, Hori T, Abd El Aal M, et al. Beta-ketothiolase deficiency: resolving challenges in diagnosis. J Inborn Errors Metab Screen. 2016;4:26409816636644.  https://doi.org/10.1177/2326409816636644.CrossRefGoogle Scholar
  2. 2.
    Wojcik MH, Wierenga KJ, Rodan LH, Sahai I, Ferdinandusse S, Genetti CA, et al. Beta-ketothiolase deficiency presenting with metabolic stroke after a normal newborn screen in two individuals. JIMD Rep. 2017;39:45–544.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Abdelkreem E, Alobaidy H, Aoyama Y, Mahmoud S, Abd El Aal M, Fukao T. Two Libyan siblings with beta-ketothiolase deficiency: a case report and review of literature. Egypt J Med Hum Genet. 2017;18(2):199–203.CrossRefGoogle Scholar
  4. 4.
    Weerasinghe WAG, Jasinge E, Sarathchandra JC, Chinthaka RAK. Intermittent episodes of metabolic ketoacidosis in a seven-year-old boy: mitochondrial Beta-ketothiolase deficiency. Galle Med J. 2013;18(1):51–3.CrossRefGoogle Scholar
  5. 5.
    Hori T, Yamaguchi S, Shinkaku H, Horikawa R, Shigematsu Y, Takayanagi M, et al. Inborn errors of ketone body utilization, c.431A>C (H144P) in ACAT1: subtle abnormality in urinary organic acid analysis and blood acylcarnitine analysis using tandem mass spectrometry. Pediatr Int. 2015;57(1):41–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Fukao T, Maruyama S, Ohura T, Hasegawa Y, Toyoshima M, Haapalainen AM, et al. Three Japanese patients with beta-ketothiolase deficiency who share a mutation. JIMD Rep. 2012;3:107–15.CrossRefPubMedGoogle Scholar
  7. 7.
    Fukao T, Scriver CR, Kondo N. The Clinical phenotype and outcome of mitochondrial acetoacetyl-CoA thiolase deficiency (β-ketothiolase or T2 deficiency) in 26 enzymatically proved and mutation-defined patients. Mol Genet Metab. 2001;72(2):109–14.CrossRefPubMedGoogle Scholar
  8. 8.
    Schutgens RBH, Middleton B, vd Blij JF, Oorthuys JWE, Veder HA, Vulsma T, et al. Beta-ketothiolase deficiency in a family confirmed by in vitro enzymatic assays in fibroblasts. Eur J Pediatr. 1982;139(1):39–42.  https://doi.org/10.1007/BF00442077.CrossRefPubMedGoogle Scholar
  9. 9.
    Nguyen KN, Nguyen HT, Can NTB, Do MTT, Bui TP, Fukao T, et al. Beta-ketothiolase deficiency: phenotype, genotype and outcome of 48 Vietnamese patients. Ann Transl Med. 2017;5(Suppl 2):AB014.Google Scholar

Copyright information

© Association of Clinical Biochemists of India 2019

Authors and Affiliations

  1. 1.Department of BiochemistryMedical Research InstituteColombo 8Sri Lanka
  2. 2.Department of Chemical PathologyLady Ridgeway Hospital for ChildrenColombo 8Sri Lanka
  3. 3.Faculty of MedicineUniversity of KelaniyaKelaniyaSri Lanka
  4. 4.Paediatric Intensive Care UnitTeaching Hospital KarapitiyaGalleSri Lanka

Personalised recommendations